JC

Jorge Conde

General Partner at Andreessen Horowitz

Menlo Park, California

VC
Investor

Invests in

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $100,000,000.00

  • Target Investment:

    $10,000,000.00

Skills

Biotechnology
Lifesciences
Business Development
Medical Devices
Start-ups
Bioinformatics
R
Entrepreneurship
Strategy
Market Research
Genomics
Venture Capital
Data Mining
Technology Transfer
Computational Biology
Product Management
Due Diligence
Genetics
Corporate Development
Life Sciences

Education

Lists including Jorge

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Tome Biosciences

Series A

Total Funding: $210M

Asimov

Series B

Total Funding: $180M

Vicinitas Therapeutics

Series A

Total Funding: $65M

CAMP4 Therapeutics

Series A

Total Funding: $180M

Octant Bio

Series A

Total Funding: $120M

EQRx

Post Ipo Equity

Total Funding: $1.2B

Dyno Therapeutics

Series A

Total Funding: $110M

Earli

Seed

Total Funding: $60M

FidoCure

Seed

Total Funding: $15M

Tmunity Therapeutics

Series B

Total Funding: $110M

Work Experience

AH
Andreessen Horowitz

2017

  • General Partner

    2017

    Investing at the cross section of biology, computer science and engineering.

VT
Vicinitas Therapeutics

2022

  • Board Member

    2022

CB
Cartography Biosciences

2022

  • Board Member

    2022

DT
Dyno Therapeutics

2021

  • Board Member

    2021

KH
Komodo Health

2020

  • Board Member

    2020

O
Octant

2019

  • Board Member

    2019

A
Asimov

2019

  • Board Member

    2019

EI
Earli Inc.

2018

  • Board Member

    2018

I
IDRx

2022 - 2025

  • Board Member

    2022 - 2025

    Acquired by GlaxoSmithKline $GSK

Tome Biosciences

2021 - 2024

  • Board Member

    2021 - 2024